Table of Contents Author Guidelines Submit a Manuscript
Pulmonary Medicine
Volume 2011, Article ID 517687, 6 pages
http://dx.doi.org/10.1155/2011/517687
Review Article

Relative Roles of TGF-β and IGFBP-5 in Idiopathic Pulmonary Fibrosis

Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, SIPBS Building, 161 Cathedral Street, Glasgow G4 0RE, UK

Received 3 September 2010; Accepted 5 January 2011

Academic Editor: Luca Richeldi

Copyright © 2011 A. Sureshbabu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. American Thoracic Society, “Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS),” American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 2 part 1, pp. 646–664, 2000. View at Google Scholar
  2. V. Tzilas, A. Koti, D. Papandrinopoulou, and G. Tsoukalas, “Prognostic factors in idiopathic pulmonary fibrosis,” American Journal of the Medical Sciences, vol. 338, no. 6, pp. 481–485, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. O. P. Sharma and K. Chan, “Idiopathic interstitial pneumonitis/fibrosis: a historical note,” Current Opinion in Pulmonary Medicine, vol. 5, no. 5, pp. 275–277, 1999. View at Google Scholar · View at Scopus
  4. S. Verma and A. S. Slutsky, “Idiopathic pulmonary fibrosis—new insights,” New England Journal of Medicine, vol. 356, no. 13, pp. 1370–1372, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. T. J. Gross and G. W. Hunninghake, “Idiopathic pulmonary fibrosis,” New England Journal of Medicine, vol. 345, no. 7, pp. 517–525, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. K. B. Baumgartner, J. M. Samet, C. A. Stidley, T. V. Colby, and J. A. Waldron, “Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis,” American Journal of Respiratory and Critical Care Medicine, vol. 155, no. 1, pp. 242–248, 1997. View at Google Scholar · View at Scopus
  7. J. Gribbin, R. B. Hubbard, I. Le Jeune, C. J. P. Smith, J. West, and L. J. Tata, “Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK,” Thorax, vol. 61, no. 11, pp. 980–985, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. A. L. Olson, J. J. Swigris, D. C. Lezotte, J. M. Norris, C. G. Wilson, and K. K. Brown, “Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003,” American Journal of Respiratory and Critical Care Medicine, vol. 176, no. 3, pp. 277–284, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. M. Governa, M. Amati, S. Fontana et al., “Role of iron in asbestos-body-induced oxidant radical generation,” Journal of Toxicology and Environmental Health A, vol. 58, no. 5, pp. 279–287, 1999. View at Google Scholar · View at Scopus
  10. K. C. Teixeira, F. S. Soares, L. G. C. Rocha et al., “Attenuation of bleomycin-induced lung injury and oxidative stress by N-acetylcysteine plus deferoxamine,” Pulmonary Pharmacology and Therapeutics, vol. 21, no. 2, pp. 309–316, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. L. S. Newman, M. M. Mroz, and A. J. Ruttenber, “Lung fibrosis in plutonium workers,” Radiation Research, vol. 164, no. 2, pp. 123–131, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. D. A. Lynch, “Lung disease related to collagen vascular disease,” Journal of Thoracic Imaging, vol. 24, no. 4, pp. 299–309, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. R. B. Hubbard, C. Smith, I. Le Jeune, J. Gribbin, and A. W. Fogarty, “The association between idiopathic pulmonary fibrosis and vascular disease: a population-based study,” American Journal of Respiratory and Critical Care Medicine, vol. 178, no. 12, pp. 1257–1261, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. M. D. Sides, R. C. Klingsberg, B. Shan et al., “The Epstein-Barr virus LMP 1 and TGF-β1 synergistically induce EMT in lung epithelial cells,” American Journal of Respiratory Cell and Molecular Biology. In press.
  15. C. E. Alpers, K. L. Hudkins, J. Floege, and R. J. Johnson, “Human renal cortical interstitial cells with some features of smooth muscle cells participate in tubulointerstitial and crescentic glomerular injury,” Journal of the American Society of Nephrology, vol. 5, no. 2, pp. 201–210, 1994. View at Google Scholar · View at Scopus
  16. I. L. Noronha, Z. Niemir, H. Stein, and R. Waldherr, “Cytokines and growth factors in renal disease,” Nephrology Dialysis Transplantation, vol. 10, no. 6, pp. 775–786, 1995. View at Google Scholar · View at Scopus
  17. G. Majno, G. Gabbiani, B. J. Hirschel, G. B. Ryan, and P. R. Statkov, “Contraction of granulation tissue in vitro: similarity to smooth muscle,” Science, vol. 173, no. 3996, pp. 548–550, 1971. View at Google Scholar · View at Scopus
  18. G. Gabbiani, G. B. Ryan, and G. Majno, “Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction,” Experientia, vol. 27, no. 5, pp. 549–550, 1971. View at Publisher · View at Google Scholar · View at Scopus
  19. P. A. Hebda, M. A. Collins, and M. D. Tharp, “Mast cell and myofibroblast in wound healing,” Dermatologic Clinics, vol. 11, no. 4, pp. 685–696, 1993. View at Google Scholar · View at Scopus
  20. M. Gharaee-Kermani, B. Hu, S. H. Phan, and M. R. Gyetko, “Recent advances in molecular targets and treatment of Idiopathic Pulmonary Fibrosis: focus on TGFβ signaling and the myofibroblast,” Current Medicinal Chemistry, vol. 16, no. 11, pp. 1400–1417, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. A. P. Sappino, W. Schurch, and G. Gabbiani, “Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations,” Laboratory Investigation, vol. 63, no. 2, pp. 144–161, 1990. View at Google Scholar · View at Scopus
  22. K. Zhang, M. D. Rekhter, D. Gordon, and S. H. Phan, “Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis: a combined immunohistochemical and in situ hybridization study,” American Journal of Pathology, vol. 145, no. 1, pp. 114–125, 1994. View at Google Scholar · View at Scopus
  23. C. J. Scotton and R. C. Chambers, “Molecular targets in pulmonary fibrosis: the myofibroblast in focus,” Chest, vol. 132, no. 4, pp. 1311–1321, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. B. Hu, Z. Wu, and S. H. Phan, “Smad3 mediates transforming growth factor-β-induced α-smooth muscle actin expression,” American Journal of Respiratory Cell and Molecular Biology, vol. 29, no. 3, part 1, pp. 397–404, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. H. Yasuoka, D. M. Jukic, Z. Zhou, A. M. K. Choi, and C. A. Feghali-Bostwick, “Insulin-like growth factor binding protein 5 induces skin fibrosis: a novel murine model for dermal fibrosis,” Arthritis and Rheumatism, vol. 54, no. 9, pp. 3001–3010, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. H. Yasuoka, Z. Zhou, J. M. Pilewski, T. D. Oury, A. M. K. Choi, and C. A. Feghali-Bostwick, “Insulin-like growth factor-binding protein-5 induces pulmonary fibrosis and triggers mononuclear cellular infiltration,” American Journal of Pathology, vol. 169, no. 5, pp. 1633–1642, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. D. C. Radisky, “Epithellial-mesenchymal transition,” Journal of Cell Science, vol. 118, no. 19, pp. 4325–4326, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. K. K. Kim, M. C. Kugler, P. J. Wolters et al., “Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 35, pp. 13180–13185, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. H. Kasai, J. T. Allen, R. M. Mason, T. Kamimura, and Z. Zhang, “TGF-β1 induces human alveolar epithelial to mesenchymal cell transition (EMT),” Respiratory Research, vol. 6, article 56, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. Z. Wu, L. Yang, L. Cai et al., “Detection of epithelial to mesenchymal transition in airways of a bleomycin induced pulmonary fibrosis model derived from an alpha-smooth muscle actin-Cre transgenic mouse,” Respiratory Research, vol. 8, article 1, 2007. View at Google Scholar
  31. B. C. Willis, R. M. DuBois, and Z. Borok, “Epithelial origin of myofibroblasts during fibrosis in the lung,” Proceedings of the American Thoracic Society, vol. 3, no. 4, pp. 377–382, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. N. Hashimoto, H. Jin, T. Liu, S. W. Chensue, and S. H. Phan, “Bone marrow-derived progenitor cells in pulmonary fibrosis,” Journal of Clinical Investigation, vol. 113, no. 2, pp. 243–252, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Ramos, C. Becerril, M. Montaño et al., “FGF-1 reverts epithelial-mesenchymal transition induced by TGF-β1 through MAPK/ERK kinase pathway,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 299, no. 2, pp. L222–L231, 2010. View at Publisher · View at Google Scholar · View at PubMed
  34. R. Kalluri and R. A. Weinberg, “The basics of epithelial-mesenchymal transition,” Journal of Clinical Investigation, vol. 119, no. 6, pp. 1420–1428, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. C. G. Lee, H. R. Kang, R. J. Homer, G. Chupp, and J. A. Elias, “Transgenic modeling of transforming growth factor-β1: role of apoptosis in fibrosis and alveolar remodeling,” Proceedings of the American Thoracic Society, vol. 3, no. 5, pp. 418–423, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. A. B. Roberts and M. B. Sporn, “Transforming growth factor-b,” in The Molecular and Cellular Biology of Wound Repair, R. A. F. Clark, Ed., pp. 275–308, Plenum Press, New York, NY, USA, 1996. View at Google Scholar
  37. K. C. Flanders, “Smad3 as a mediator of the fibrotic response,” International Journal of Experimental Pathology, vol. 85, no. 2, pp. 47–64, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. C. K. Miranti and J. S. Brugge, “Sensing the environment: a historical perspective on integrin signal transduction,” Nature Cell Biology, vol. 4, no. 4, pp. E83–E90, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. R. O. Hynes, “Integrins: bidirectional, allosteric signaling machines,” Cell, vol. 110, no. 6, pp. 673–687, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. R. Zaidel-Bar, S. Itzkovitz, A. Ma'ayan, R. Iyengar, and B. Geiger, “Functional atlas of the integrin adhesome,” Nature Cell Biology, vol. 9, no. 8, pp. 858–867, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. J. S. Munger, X. Huang, H. Kawakatsu et al., “The integrin αvβ6 binds and activates latent TGFβ1: a mechanism for regulating pulmonary inflammation and fibrosis,” Cell, vol. 96, no. 3, pp. 319–328, 1999. View at Publisher · View at Google Scholar · View at Scopus
  42. J. P. Annes, Y. Chen, J. S. Munger, and D. B. Rifkin, “Integrin αβ-mediated activation of latent TGF-β requires the latent TGF-β binding protein-1,” Journal of Cell Biology, vol. 165, no. 5, pp. 723–734, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. D. C. Howell, G. J. Laurent, and R. C. Chambers, “Role of thrombin and its major cellular receptor, protease-activated receptor-1, in pulmonary fibrosis,” Biochemical Society Transactions, vol. 30, no. 2, pp. 211–216, 2002. View at Google Scholar · View at Scopus
  44. M. Y. Xu, J. Porte, A. J. Knox et al., “Lysophosphatidic acid induces αvβ36 integrin-mediated TGF-β activation via the LPA2 receptor and the small G protein Gα(q),” American Journal of Pathology, vol. 174, no. 4, pp. 1264–1279, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. S. L. Nishimura, “Integrin-mediated transforming growth factor-β activation, a potential therapeutic target in fibrogenic disorders,” American Journal of Pathology, vol. 175, no. 4, pp. 1362–1370, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. J. Beattie, G. J. Allan, J. D. Lochrie, and D. J. Flint, “Insulin-like growth factor-binding protein-5 (IGFBP-5): a critical member of the IGF axis,” Biochemical Journal, vol. 395, no. 1, pp. 1–19, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. J. M. Pilewski, L. Liu, A. C. Henry, A. V. Knauer, and C. A. Feghali-Bostwick, “Insulin-like growth factor binding proteins 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition,” American Journal of Pathology, vol. 166, no. 2, pp. 399–407, 2005. View at Google Scholar · View at Scopus
  48. C. A. Feghali and T. M. Wright, “Identification of multiple, differentially expressed messenger RNAs in dermal fibroblasts from patients with systemic sclerosis,” Arthritis and Rheumatism, vol. 42, no. 7, pp. 1451–1457, 1999. View at Publisher · View at Google Scholar · View at Scopus
  49. X. Huang, J. Wu, W. Zhu, R. Pytela, and D. Sheppard, “Expression of the human integrin β6 subunit in alveolar type II cells and bronchiolar epithelial cells reverses lung inflammation in β6 knockout mice,” American Journal of Respiratory Cell and Molecular Biology, vol. 19, no. 4, pp. 636–642, 1998. View at Google Scholar · View at Scopus
  50. A. Sureshbabu, H. Okajima, D. Yamanaka et al., “IGFBP-5 induces epithelial and fibroblast responses consistent with the fibrotic response,” Biochemical Society Transactions, vol. 37, no. 4, pp. 882–885, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  51. T. Q. Nguyen and R. Goldschmeding, “Bone morphogenetic protein-7 and connective tissue growth factor: novel targets for treatment of renal fibrosis?” Pharmaceutical Research, vol. 25, no. 10, pp. 2416–2426, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  52. I. Inoki, T. Shiomi, G. Hashimoto et al., “Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis,” FASEB Journal, vol. 16, no. 2, pp. 219–221, 2002. View at Google Scholar · View at Scopus
  53. J. G. Abreu, N. I. Ketpura, B. Reversade, and E. M. de Robertis, “Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-β,” Nature Cell Biology, vol. 4, no. 8, pp. 599–604, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  54. C. K. Abrass and K. M. Hansen, “Insulin-like growth factor-binding protein-5-induced laminin γ1 transcription requires filamin A,” Journal of Biological Chemistry, vol. 285, no. 17, pp. 12925–12934, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  55. V. Hwa, Y. Oh, and R. G. Rosenfeld, “Insulin-like growth factor binding protein-3 and -5 are regulated by transforming growth factor-β and retinoic acid in the human prostate adenocarcinoma cell line PC-3,” Endocrine, vol. 6, no. 3, pp. 235–242, 1997. View at Google Scholar · View at Scopus
  56. D. LeRoith, M. L. Adamo, J. Shemer et al., “Retinoic acid inhibits growth of breast cancer cell lines: the role of insulin-like growth factor binding proteins,” Growth Regulation, vol. 3, no. 1, pp. 78–80, 1993. View at Google Scholar · View at Scopus
  57. T. Nickerson and H. Huynh, “Vitamin D analogue EB1089-induced prostate regression is associated with increased gene expression of insulin-like growth factor binding proteins,” Journal of Endocrinology, vol. 160, no. 2, pp. 223–229, 1999. View at Publisher · View at Google Scholar · View at Scopus